Rahma Ziska
Master's Program in Pharmaceutical Sciences, Faculty of Pharmacy, Universitas Bhakti Kencana, Bandung, Indonesia

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

Pharmacogenomic Interactions in Antihypertensive Drug Polypharmacy and their Association with Intradialytic Complications in Chronic Kidney Disease Patients Undergoing Hemodialysis Chairiati Chairiati; Inge Maharani Ivo; Rahma Ziska
Journal of Community Health Provision Vol. 6 No. 2 (2026): Journal of Community Health Provision
Publisher : PSPP JOURNALS

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.55885/jchp.v6i2.1040

Abstract

This study aims to synthesize scientific evidence on pharmacogenomic interactions in antihypertensive drug polypharmacy and their association with intradialytic complications in patients with chronic kidney disease (CKD) undergoing hemodialysis through a Systematic Literature Review (SLR) approach. A systematic search of PubMed, Scopus, Web of Science Core Collection, Google Scholar, and Wiley Online Library was conducted for studies published from 2017 to 2025. The review was reported in accordance with PRISMA 2020, although the protocol was not prospectively registered. Evidence from maintenance hemodialysis populations was synthesized separately from contextual pharmacogenomic evidence derived from non-dialysis or mixed CKD populations. A total of 30 articles met the inclusion criteria and were synthesized narratively. The review findings indicate that antihypertensive polypharmacy is highly prevalent in the hemodialysis population, with an average use of ≥5–10 medications. The most frequently reported pharmacogenomic interactions involve phase I drug-metabolizing genes, particularly CYP2D6 and CYP2C9, which influence responses to beta-blockers and angiotensin receptor blockers (ARBs). Drug–drug–gene interactions under intensive polypharmacy conditions increase the risk of intradialytic hypotension, intradialytic hypertension, bradycardia, electrolyte disturbances, and reduced quality of life. This synthesis confirms that intradialytic complications are influenced not only by drug class or timing of administration, but also by the combination of genetic factors, kidney function, and medication burden. The integration of pharmacogenomic approaches, polypharmacy evaluation, and the involvement of clinical pharmacists has the potential to improve patient safety and hemodynamic stability in hemodialysis patients.
Microbiome Modulation in Acne Vulgaris: Comprehensive Narative Review of Oral-Topical Biotics and Future Challenges Dzakiyya Nur Dhiya; Imelda Matruty; Rahma Ziska
Journal of Community Health Provision Vol. 6 No. 2 (2026): Journal of Community Health Provision
Publisher : PSPP JOURNALS

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.55885/jchp.v6i2.1041

Abstract

Acne vulgaris is a skin disease with a high prevalence, whose pathophysiology involves microbiome dysbiosis, inflammation, and dysregulation of skin barrier function. The long-term use of antibiotics as the primary therapy can raise concerns about resistance, necessitating alternative approaches based on microbiome modulation. Objective: This narrative review aims to synthesize the latest primary evidence on biotic interventions (prebiotics, probiotics, postbiotics, and synbiotics) for acne vulgaris, administered via both oral and topical routes, and to compare the mechanisms of action, benefits, and limitations of each route of administration. Methods: Primary literature search in several databases, such as PubMed, MDPI, SpringerLink, Wiley Online Library, ScienceDirect, and Google Scholar. Priority literature examples are RCTs (randomized controlled trials) or clinical trials published within the last 7 years that discuss the use of biotic interventions for acne vulgaris. Results: Data synthesis indicates that topical biotic interventions containing postbiotics provide faster and more consistent clinical improvement in reducing inflammatory lesions, acne severity scores, and sebum parameters. Conversely, oral biotic interventions show longer-lasting and more variable effects, primarily through modulation of the gut-skin axis and systemic inflammation. Conclusion: Biotic interventions have potential as an alternative or supportive therapeutic approach for acne vulgaris, with oral postbiotics showing the most consistent benefit profile. However, further research with standardized designs and direct comparative testing is needed to strengthen the clinical evidence and its mechanistic action.